PathCare would like to inform you that, with immediate effect, the Bilharzia Urine CCA (circulating cathodic antigen) test will no longer be performed at our diagnostic laboratories. Our supplier has advised that the test kits cannot currently be produced, owing to manufacturing problems with the Schistosoma antibodies used in the kits and the lack of a suitable alternative that meets WHO product specifications. No other commercial urine CCA kits are currently SAHPRA approved. We apologise for any inconvenience this may cause.
Discontinuation of Urine Bilharzia CCA Antigen test